Terms: = Ovarian cancer AND ARNT, HIF1BETA, 405, ENSG00000143437, P27540, HIF-1beta, HIF1B, TANGO AND Prognosis
11 results:
1. Prognostic predictors in recurrent adult granulosa cell tumors of the ovary: a systematic review and meta-analysis.
Inzani F; Santoro A; Travaglino A; D'Alessandris N; Raffone A; Straccia P; Angelico G; Arciuolo D; Scaglione G; Valente M; Tralongo P; Gallotta V; Zannoni GF
Arch Gynecol Obstet; 2022 Aug; 306(2):315-321. PubMed ID: 34799743
[TBL] [Abstract] [Full Text] [Related]
2. Determination of Potential Therapeutic Targets and Prognostic Markers of ovarian cancer by Bioinformatics Analysis.
Zhang J; Huang S; Quan L; Meng Q; Wang H; Wang J; Chen J
Biomed Res Int; 2021; 2021():8883800. PubMed ID: 33829065
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic value of an autophagy-related long-noncoding-RNA signature for endometrial cancer.
Wang X; Dai C; Ye M; Wang J; Lin W; Li R
Aging (Albany NY); 2021 Feb; 13(4):5104-5119. PubMed ID: 33534780
[TBL] [Abstract] [Full Text] [Related]
4. Gender Disparity in Referral for Definitive Care of Malignant Pleural Effusions.
Foote DC; Burke CR; Pandian B; Banks S; Haug KL; Hipp M; Zhao L; Smola B; Roh M; Carrott PW; Lynch WR; Chang AC; Lin J; Reddy RM
J Surg Res; 2019 Dec; 244():409-416. PubMed ID: 31325663
[TBL] [Abstract] [Full Text] [Related]
5. Predicting Response to Standard First-line Treatment in High-grade Serous ovarian Carcinoma by Angiogenesis-related Genes.
Mendiola M; Redondo A; Heredia-Soto V; Herranz J; Berjón A; Hernández A; Miguel-Martín M; Crespo R; Barriuso J; Cruz P; Yébenes L; Peláez-García A; Castelo B; DE Molina AR; Feliu J; Hardisson D
Anticancer Res; 2018 Sep; 38(9):5393-5400. PubMed ID: 30194194
[TBL] [Abstract] [Full Text] [Related]
6. Impact of ovarian metastases on survival in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancy originating from appendiceal and colorectal cancer.
Bignell MB; Mehta AM; Alves S; Chandrakumaran K; Dayal SP; Mohamed F; Cecil TD; Moran BJ
Colorectal Dis; 2018 Aug; 20(8):704-710. PubMed ID: 29502336
[TBL] [Abstract] [Full Text] [Related]
7. Vascular Endothelial Growth Factor (VEGF) Polymorphisms and Serum VEGF Levels in Women With Epithelial ovarian cancer, Benign Tumors, and Healthy Ovaries.
González-Palomares B; Coronado Martín PJ; Maestro de Las Casas ML; Veganzones de Castro S; Rafael Fernández S; Vidaurreta Lázaro M; De la Orden García V; Vidart Aragon JA
Int J Gynecol Cancer; 2017 Jul; 27(6):1088-1095. PubMed ID: 28574932
[TBL] [Abstract] [Full Text] [Related]
8. Prediction value of intercellular adhesion molecule-1 gene polymorphisms for epithelial ovarian cancer risk, clinical features, and prognosis.
Cai G; Ma X; Zou W; Huang Y; Zhang J; Wang D; Chen B
Gene; 2014 Aug; 546(1):117-23. PubMed ID: 23933413
[TBL] [Abstract] [Full Text] [Related]
9. Role of surgery in the treatment of ovarian metastases from colorectal cancer.
Chung TS; Chang HJ; Jung KH; Park SY; Lim SB; Choi HS; Jeong SY
J Surg Oncol; 2009 Dec; 100(7):570-4. PubMed ID: 19722226
[TBL] [Abstract] [Full Text] [Related]
10. Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma.
Rosen DG; Yang G; Deavers MT; Malpica A; Kavanagh JJ; Mills GB; Liu J
Cancer; 2006 May; 106(9):1925-32. PubMed ID: 16568440
[TBL] [Abstract] [Full Text] [Related]
11. 9-beta-D-arabinofuranosyl-2-fluoroadenine inhibits expression of vascular endothelial growth factor through hypoxia-inducible factor-1 in human ovarian cancer cells.
Fang J; Cao Z; Chen YC; Reed E; Jiang BH
Mol Pharmacol; 2004 Jul; 66(1):178-86. PubMed ID: 15213310
[TBL] [Abstract] [Full Text] [Related]
